[1] Shi H, Wang C, Qiang W, et al.Case Report: Successful Control of Pulmonary Metastatic Pheochromocytoma With Iodine-125 Seed Implantation[J]. Frontiers in Endocrinology, 2021, 12: 714006.
[2] Seniwal B, Thipe VC, Singh S, et al.Recent Advances in Brachytherapy Using Radioactive Nanoparticles: An Alternative to Seed-Based Brachytherapy[J]. Frontiers in Oncology, 2021, 11: 766407.
[3] Hu P, Huang J, Zhang Y, et al.Iodine-125 seed implantation in the treatment of malignant tumors[J]. Journal of Interventional Medicine, 2023, 6(3): 111-115.
[4] Yu N, Shen Y, Wu Y, et al.Commissioning for 125I Production Loop Simulation System by Reactor Irradiation[J]. Journal of Isotopes, 2018, 31(1): 104-109.
[5] Xiao L, Tang J, Li W, et al.Improved prognosis for recurrent epithelial ovarian cancer by early diagnosis and 125I seeds implantation during suboptimal secondary cytoreductive surgery: a case report and literature review[J]. Journal of Ovarian Research, 2020, 13(1): 141.
[6] Liang Y, Wang Z, Zhang H, et al.Three-dimensional-printed individual template-guided 125I seed implantation for the cervical lymph node metastasis: A dosimetric and security study[J]. J Cancer Res Ther, 2018,14(1): 30-35.
[7] 李冰. 前列腺粒子植入机器人精准穿刺控制方法研究[D]. 哈尔滨:哈尔滨理工大学,2023.
[8] Wang Y, Zhu L, Lin X, et al.Therapeutic Effect of CT-guided 125I Seed Implantation on Advanced Lung Cancer and Pulmonary Metastatic Carcinoma[J]. Zhongguo Fei Ai Za Zhi, 2020, 23(6): 424-428.
[9] 杜随. 不同剂量125I粒子治疗非小细胞肺癌的临床观察[D]. 石家庄:河北医科大学,2019.
[10] 何玉,张磊,李丽琼. 经导管动脉栓塞化疗联合放射性粒子对原发性肝癌患者疗效研究[J]. 西藏医药,2024,45(1):23-25.
[11] 鲁月. CT引导下放射性125I粒子植入治疗肝脏特殊部位肿瘤的临床研究[D]. 济南:山东大学,2024.
[12] Dickinson PD, Malik J, Mandall P, et al.Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK[J]. BJU Int, 2014, 113(5): 748-753.
[13] Zhaoyuan X, Xingxia L, Zhen W, et al.Clinical analysis of three dimensional conformal 125I of nCRPC[J]. Yixue Yingxiangxue Zazhi, 2023, 33(1): 79-81.
[14] Yaxley JW, Lah K, Yaxley JP, et al.Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years[J]. BJU Int, 2017, 120(1): 56-60.
[15] Abugharib AE, Dess RT, Soni PD, et al.External beam radiation therapy with or without low-dose-rate brachytherapy: Analysis of favorable and unfavorable intermediate-risk prostate cancer patients[J]. Brachytherapy, 2017, 16(4): 782-789.
[16] 李华福,谢群,叶啸,等. 粒子植入近距离放射治疗与外放射治疗对局限性前列腺癌疗效比较的Meta分析[J]. 放射学实践,2018,33(9):950-955.
[17] 刘颖,冉林浩,黄学全. CT引导下植入125I放射性粒子应用于胰腺癌治疗的临床价值研究[J]. 中国CT和MRI杂志,2021, 19(2):105-107.
[18] 贺安利. CT引导下125I放射性粒子植入联合GS化疗方案治疗中晚期胰腺癌的临床价值[J]. 宁夏医学杂志,2018,40(8):717-719.
[19] Wang Y, Kang P, He W, et al.MR-guided 125I seed implantation treatment for maxillofacial malignant tumor[J]. J Appl Clin Med Phys, 2021,22(1): 92-99.
[20] Stone NN, Stock RG.Permanent seed implantation for localized adenocarcinoma of the prostate[J]. Current Urology Reports, 2002, 3(3): 201-206.
[21] 杨剑,耿建华,洪浩,等. 125I粒子植入治疗的前列腺癌患者出院后对周围人员辐射水平的研究[J]. 中国医学装备,2018,15(4):23-27. |
